Martin Voelkl
About Martin Voelkl
Martin Voelkl is the Executive Director and GM for Germany and Austria at BeiGene, with extensive experience in the pharmaceutical industry.
Company
Martin Voelkl is currently employed at BeiGene, a global biotechnology company specializing in molecularly targeted and immuno-oncology drug development. He holds the position of Executive Director, GM Germany & Austria, and operates out of München, Germany.
Title
Martin Voelkl serves as the Executive Director and General Manager for Germany and Austria at BeiGene. He has been in this role since April 2021.
Previous Roles at Portola Pharmaceuticals
Prior to joining BeiGene, Martin Voelkl worked at Portola Pharmaceuticals where he was the General Manager for Germany and Austria. His tenure lasted from 2019 to 2020, and he was based in Martinsried, Germany.
Previous Roles at Celgene
Martin Voelkl spent 12 years at Celgene, serving as the Director of Market Access and Corporate Affairs. He worked there from 2007 to 2019, primarily in Munich, Germany. During his time at Celgene, he gained over a decade of experience in market access and corporate affairs.
Pharmaceutical Industry Experience
Martin Voelkl has extensive experience in the pharmaceutical industry, especially within the German and Austrian markets. His career spans significant roles in market access, corporate affairs, and general management in leading pharmaceutical companies such as Celgene, Portola Pharmaceuticals, and currently BeiGene.